| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Core Laboratories Inc. /DE/ | SVP & CFO | Common Stock | 72,049 | $1.27 M | $17.66 | Dec 31, 2023 | Direct |
| Core Laboratories Inc. /DE/ | SVP & CFO | Performance Shares | 79,442 | Feb 15, 2024 | Direct | ||
| CORE LABORATORIES N V | SVP & CFO | Performance Shares | 52,718 | Feb 16, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLB | Core Laboratories Inc. /DE/ | Feb 15, 2024 | 1 | 0 | 4 | Feb 15, 2024 | SVP & CFO |
| CLB | Core Laboratories Inc. /DE/ | Dec 31, 2023 | 1 | -250,684 | 4/A | Jan 8, 2024 | SVP & CFO |
| CLB | Core Laboratories Inc. /DE/ | Dec 31, 2023 | 3 | -244,944 | 4 | Jan 3, 2024 | SVP & CFO |
| CLB | CORE LABORATORIES N V | Feb 16, 2023 | 1 | 0 | 4 | Feb 21, 2023 | SVP & CFO |
| CLB | CORE LABORATORIES N V | Dec 31, 2022 | 3 | -252,767 | 4 | Jan 4, 2023 | SVP & CFO |
| CLB | CORE LABORATORIES N V | Feb 17, 2022 | 1 | 0 | 4 | Feb 17, 2022 | SVP & CFO |
| CLB | CORE LABORATORIES N V | Dec 31, 2021 | 3 | -206,568 | 4 | Jan 4, 2022 | SVP & CFO |